0001171843-22-001906.txt : 20220315
0001171843-22-001906.hdr.sgml : 20220315
20220315170147
ACCESSION NUMBER: 0001171843-22-001906
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220311
FILED AS OF DATE: 20220315
DATE AS OF CHANGE: 20220315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colleran David
CENTRAL INDEX KEY: 0001646558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 22742046
MAIL ADDRESS:
STREET 1: 600 TECHNOLOGY PARK DRIVE
STREET 2: SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0306
4
2022-03-11
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001646558
Colleran David
32 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
EVP, General Counsel, Corp Sec
Restricted Stock Unit
0.00
2022-03-11
4
A
0
22988
0
A
Common Stock
22988
22988
D
Stock Option (Right to Buy)
28.14
2022-03-11
4
A
0
35864
0
A
2032-03-11
Common Stock
35864
35864
D
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
The premium priced stock options vest in three equal annual installments beginning on March 11, 2023.
/s/ David Colleran
2022-03-15